Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), and Terumo BCT, Inc. (U.S) to Dominate the Global Apheresis Market

By -

The Global Apheresis Market is projected to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% from 2016 to 2021.

(EMAILWIRE.COM, December 24, 2018 ) The global Apheresis Market is consolidated and highly competitive, with the top five players accounting for ~ 85% of the market share in 2015.

In this consolidated market, Haemonetics Corporation (U.S.), Fresenius Medical Care, and Terumo BCT, Inc. are the leading players. Other players in this market include Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). A majority of the leading players in this market are based in developed countries across North America and Europe.

Get Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

The leading position of Haemonetics Corporation is attributed to its wide product portfolio in both devices and disposables segments. The company has a wide geographic presence across the U.S., Europe, Japan, and other parts of Asia, which enables it to cater to customers across the globe. Around 50% of the company’s revenue is generated from the U.S. market. The company mainly focuses on agreements and acquisitions to maintain its position in the market.

Fresenius Medical Care is another leading company in the market. This is attributed to the company’s strong presence in North America, Europe, Asia-Pacific, Latin America, and Africa. The company is also expanding its presence in the emerging markets by strengthening its business operations in those markets. In order to increase its market share and revenue, the company pursues the strategy of product launch and acquisitions.

A majority of the top players adopted product launches; acquisitions, agreements, collaborations, and partnerships; and geographic expansions as their key growth strategies. Agreements, partnerships, and collaborations were the preferred strategy adopted by key players in the global apheresis market. For instance, in December 2016, Fresenius Kabi USA and Terumo Cardiovascular Group (U.S.) entered into a five-year distribution agreement for Fresenius Kabi’s CATSmart, a continuous autotransfusion system.

This agreement allowed Fresenius Kabi to meet their customers’ need for allogeneic blood transfusions. Similarly, in October 2016, Cerus Corporation (U.S.) entered into a distribution agreement with Hemolife Fundación Banco Nacional de Sangre (Colombia) to supply Cerus’s INTERCEPT Blood System to hospitals in Colombia.

You Can Also Request to Get 10% FREE Customization@
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=950

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more